ARTICLE | Company News
Lundbeck, Otsuka submit brexpiprazole NDA
July 14, 2014 11:28 PM UTC
H. Lundbeck A/S (CSE:LUN) and Otsuka Pharmaceutical Co. Ltd. (Tokyo, Japan) submitted an NDA to FDA for brexpiprazole ( OPC-34712) to treat schizophrenia and as an adjunct for major depressive disorde...